≡ Risteys
R10

Documentation Changelog GitHub Contact & Feedback

Diabetes, insulin treatment (Kela reimbursement) (more control exclusions)

Endpoint Browser PheWeb

KELA_DIAB_INSUL_EXMORE

No definition available.

Endpoint definition

↥
FinnGen phenotype data

individuals

diagram downward connector

Apply sex-specific rule None

diagram downward connector

Check conditions None

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

KELA reimbursements: KELA codes 103

1 out of 7 registries used, show all original rules.

-

diagram downward connector

Check minimum number of events None

-

diagram downward connector

Include endpoints None

-

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

62366

diagram downward connector
KELA_DIAB_INSUL_EXMORE

Control definitions

Control exclude DIABETES_FG

Extra metadata

First used in FinnGen datafreeze DF2

No upset plot: script not run.

No upset table: script not run.

Similar endpoints

↥

List of similar endpoints to Diabetes, insulin treatment (Kela reimbursement) (more control exclusions) based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Broader endpoints:

Venn diagram with a set fully inside an highlighted set Narrower endpoints:

Show all endpoint correlations

Summary Statistics

↥

Key figures

All Female Male
Number of individuals 62366 27284 35082
Unadjusted prevalence (%) 15.14 11.85 19.30
Mean age at first event (years) 55.42 54.34 56.26

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.05 2.46 [2.21, 2.73] 5.4e-61 10808
15 years 0.01 1.79 [1.64, 1.95] 6.9e-40 5392
5 years 0.00 2.50 [2.33, 2.69] <1e-100 2491
1 year 0.00 3.57 [3.18, 4.00] <1e-100 665

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: KELA_DIAB_INSUL_EXMORE – Diabetes, insulin treatment (Kela reimbursement) (more control exclusions)
GWS hits: 215

Survival analyses between endpoints

↥

Plot

before Diabetes, insulin treatment (Kela reimbursement) (more control exclusions)
after Diabetes, insulin treatment (Kela reimbursement) (more control exclusions)

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Diabetes, insulin treatment (Kela reimbursement) (more control exclusions)

↥

Endpoint not on priority list, no data to show.